A TCD test, or transcranial Doppler ultrasound, is a noninvasive exam that measures blood flow speed inside the arteries of your brain. It uses a handheld ultrasound probe pressed against your skull to detect how fast red blood cells are moving through major blood vessels, without needles, radiation, or contrast dye. The test typically takes 30 to 60 minutes and requires no special preparation.
How the Test Works
The probe sends low-frequency ultrasound waves through your skull. These waves bounce off moving red blood cells and return to the probe at a slightly different frequency. That frequency shift is directly proportional to how fast the blood is flowing, so the machine can calculate velocity in real time. A standard TCD uses a 2 MHz probe, which is lower than the frequency used for other ultrasound exams. Higher frequencies can’t penetrate the skull well enough to reach the brain’s arteries.
Even with the lower frequency, the ultrasound can only pass through naturally thinner areas of the skull called acoustic windows. The most common window is the temporal bone, just above and in front of the ear. Your technician will also check through the back of the skull near the base and sometimes through the eye socket to reach different arteries. The main targets are the arteries that form the circle of Willis, a ring of blood vessels at the base of the brain that supplies most of its blood flow.
What Happens During the Test
You’ll either lie on a padded table or sit in a chair. The technician applies a water-soluble gel to your skin over the area being examined, then holds the probe against your skull. You’ll need to keep your head still and avoid talking while the measurements are taken. There’s no pain involved.
You don’t need to change into a hospital gown or remove jewelry. If you wear contact lenses, your provider may ask you to take them out beforehand. If you wear a head covering, the technician will discuss options for adjusting or temporarily removing it. For certain versions of the test (like a bubble study, described below), a small IV line is placed in your arm so saline can be injected.
Why Doctors Order a TCD
The test is used in several distinct clinical situations, all centered on one question: is blood flowing through the brain’s arteries the way it should be?
Sickle Cell Disease Screening
Stroke is a major cause of disability and death in children with sickle cell disease. TCD can detect dangerously fast blood flow in narrowed arteries before a stroke happens, making early prevention with transfusion therapy possible. The American Society of Hematology recommends annual TCD screening for children ages 2 to 16 with the most common forms of sickle cell disease (HbSS and HbSβ0 thalassemia). This is one of the most well-established uses of the test, because it’s safe, low-cost, and well tolerated by children.
Vasospasm After Brain Hemorrhage
When a blood vessel in the brain ruptures (a subarachnoid hemorrhage), surrounding arteries can go into spasm days later, dangerously restricting blood flow. TCD can catch this early by tracking velocity changes over time. Blood flow above 120 cm/s in the middle cerebral artery, for example, is one of the standard criteria for vasospasm. Doctors also use a ratio comparing intracranial and extracranial flow speeds to distinguish true vessel spasm from a general increase in blood flow. In intensive care units, TCD is often repeated daily to watch for these changes.
Stroke Risk and Evaluation
Beyond sickle cell disease, TCD helps evaluate narrowing or blockages in the brain’s arteries that could lead to stroke. It can identify areas where blood is moving too fast (a sign of narrowing) or too slow (a sign of reduced flow). Because it’s portable and repeatable, it’s useful for ongoing monitoring in patients who’ve already had a stroke or transient ischemic attack.
Bubble Study for Heart Defects
A TCD bubble test screens for a patent foramen ovale, a small hole between the heart’s upper chambers that’s present in roughly one in four adults. During this version of the test, saline mixed with tiny air bubbles is injected through an IV. If there’s a hole in the heart, those microbubbles cross from the right side to the left and travel up to the brain, where the TCD probe detects them in the middle cerebral artery. This is particularly useful when someone has had an unexplained stroke and doctors suspect a clot may have passed through the heart rather than forming in the brain’s own vessels.
Brain Death Assessment
In critical care, TCD serves as supporting evidence when doctors are evaluating whether brain death has occurred. As pressure inside the skull rises and blood flow to the brain stops, the TCD shows characteristic patterns: first blood flows forward only during heartbeats, then it oscillates (flowing forward and backward in equal measure), and finally only tiny systolic spikes appear before all signal disappears. These patterns confirm that blood is no longer reaching the brain.
What the Results Mean
TCD results are reported as blood flow velocities, measured in centimeters per second. Normal values vary by artery and by age. In the middle cerebral artery, the most commonly measured vessel, average flow velocity in adults is roughly 50 to 60 cm/s. Velocities well above normal suggest narrowing. Velocities below normal can indicate reduced blood flow or a blockage further upstream.
In sickle cell screening, the key threshold is a time-averaged mean velocity above 200 cm/s, which places a child in the high-risk category for stroke. Values between 170 and 199 cm/s are considered conditionally elevated and typically prompt more frequent monitoring.
Standard TCD vs. Color-Coded Imaging
The original TCD is a “blind” technique. It measures blood flow without producing an image of the artery itself. The technician identifies vessels based on probe position, depth, and flow direction. A newer version called transcranial color-coded Doppler (TCCD) combines traditional ultrasound imaging with color-coded blood flow, letting the operator actually see the arteries on screen and place the measurement point more precisely.
In practice, the color-coded version tends to produce slightly higher velocity readings because it can correct for the angle between the ultrasound beam and the artery. One comparative study found that angle-corrected TCCD measured middle cerebral artery peak velocities about 10 cm/s higher than standard TCD. Without angle correction, though, the two techniques give nearly identical numbers. Most established clinical thresholds, like the sickle cell screening cutoffs, were developed using the original non-imaging TCD, so that version remains the standard for many applications.
Limitations of the Test
About 5 to 20 percent of patients, particularly older women and people with thicker skulls, have inadequate acoustic windows, meaning the ultrasound simply can’t get through well enough to produce reliable readings. The test also measures velocity rather than actual blood volume, so results can be influenced by factors like anemia, fever, or high cardiac output that speed up flow without any change in the arteries themselves. And because standard TCD doesn’t produce an image, it can struggle to distinguish between individual vessels when anatomy varies from the norm. These are reasons your doctor may follow up with additional imaging like CT angiography or MRI when TCD results are unclear.